Pacira Pharmaceuticals Inc (PCRX)

Return on assets (ROA)

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net income	US$ in thousands	41,955	15,909	41,980	145,523	-11,016
Total assets	US$ in thousands	1,574,390	1,681,200	2,075,350	1,274,510	831,065
ROA		2.66%	0.95%	2.02%	11.42%	-1.33%

December 31, 2023 calculation

ROA = Net income ÷ Total assets
= $41,955K ÷ $1,574,390K
= 2.66%

Based on the provided data, Pacira BioSciences Inc's return on assets (ROA) has exhibited fluctuations over the past five years. In 2023, the ROA stands at 2.66%, showing an improvement compared to 2022 when it was 0.95%. This indicates that the company generated $2.66 in net income for every $100 of assets in 2023.

In 2021, the ROA was 2.02%, which was lower than the previous year of 11.42% in 2020. The significant drop in ROA from 2020 to 2021 suggests a decrease in the company's efficiency in generating profits from its assets during that period.

Furthermore, in 2019, Pacira BioSciences Inc experienced a negative ROA of -1.33%, indicating that the company incurred losses relative to its asset base in that year.

Overall, the improvement in ROA from 2022 to 2023 is a positive sign, but it is essential to monitor the trend in conjunction with other financial metrics to assess the company's operational efficiency and profitability in the long term.